Effect of phytosterols/stanols on LDL concentration and other surrogate markers of cardiovascular risk

Diabetes and Metabolism

Volumn 41, Issue 1, 2015, Pages 69-75

  Bard, J M ^a,b   Paillard, F ^c   Lecerf, J M ^d  

^a UNIVERSITÉ DE NANTES   (France)

^b UMR INSERM U892 CNRS 6299   (France)

^c PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^d INSTITUT PASTEUR DE LILLE   (France)

Author keywords

Cardiovascular risk markers; LDL cholesterol; Plant sterols

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN; MARGARINE; OLIVE OIL; PHYTOSTEROL; SITOSTANOL; STANOZOLOL; TRIACYLGLYCEROL; BIOLOGICAL MARKER; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ARTERIAL WALL THICKNESS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DISEASE MARKER; DRUG EFFECT; DRUG EFFICACY; ENDOTHELIAL DYSFUNCTION; HUMAN; HYPERCHOLESTEROLEMIA; INFLAMMATION; LIPOPROTEIN BLOOD LEVEL; LOW FAT DIET; MEDITERRANEAN DIET; META ANALYSIS (TOPIC); MICROCIRCULATION; OXIDATIVE STRESS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; TRIACYLGLYCEROL BLOOD LEVEL; VASCULAR ENDOTHELIUM; VASODILATATION; BLOOD; CARDIOVASCULAR DISEASES; CHEMISTRY; DRUG EFFECTS; ERYTHROCYTE; RISK FACTOR;

BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CHOLESTEROL, LDL; ERYTHROCYTES; HUMANS; OXIDATIVE STRESS; PHYTOSTEROLS; RISK FACTORS;

EID: 84921711054     PISSN: 12623636     EISSN: 18781780     Source Type: Journal    
DOI: 10.1016/j.diabet.2014.11.006     Document Type: Review

References (51)

1. Hendriks H.F., Weststrate J.A., van Vliet T., Meijer G.W. Spreads enriched with three different levels of vegetable oil sterols and the degree of cholesterol lowering in normocholesterolaemic and mildly hypercholesterolaemic subjects. Eur J Clin Nutr 1999, 53:319-327.
2. Weststrate J.A., Meijer G.W. Plant sterol-enriched margarines and reduction of plasma total- and LDL-cholesterol concentrations in normocholesterolaemic and mildly hypercholesterolaemic subjects. Eur J Clin Nutr 1998, 52:334-343.
3. Katan M.B., Grundy S.M., Jones P., Law M., Miettinen T., Paoletti R. Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels. Mayo Clin Proc 2003, 78:965-978.
4. AbuMweis S.S., Barake R., Jones P.J. Plant sterols/stanols as cholesterol lowering agents: a meta-analysis of randomized controlled trials. Food Nutr Res 2008, 52.
5. Demonty I., Ras R.T., van der Knaap H.C., Duchateau G.S., Meijer L., Zock P.L., et al. Continuous dose-response relationship of the LDL-cholesterol-lowering effect of phytosterol intake. J Nutr 2009, 139:271-284.
6. Miettinen T.A., Puska P., Gylling H., Vanhanen H., Vartiainen E. Reduction of serum cholesterol with sitostanol-ester margarine in a mildly hypercholesterolemic population. N Engl J Med 1995, 333:1308-1312.
7. Hendriks H.F., Brink E.J., Meijer G.W., Princen H.M., Ntanios F.Y. Safety of long-term consumption of plant sterol esters-enriched spread. Eur J Clin Nutr 2003, 57:681-692.
8. Amundsen A.L., Ntanios F., Put N., Ose L. Long-term compliance and changes in plasma lipids, plant sterols and carotenoids in children and parents with FH consuming plant sterol ester-enriched spread. Eur J Clin Nutr 2004, 58:1612-1620.
9. Athyros V.G., Kakafika A.I., Papageorgiou A.A., Tziomalos K., Peletidou A., Vosikis C., et al. Effect of a plant stanol ester-containing spread, placebo spread, or Mediterranean diet on estimated cardiovascular risk and lipid, inflammatory and haemostatic factors. Nutr Metab Cardiovasc Dis 2011, 21:213-221.
10. O'Neill F.H., Sanders T.A., Thompson G.R. Comparison of efficacy of plant stanol ester and sterol ester: short-term and longer-term studies. Am J Cardiol 2005, 96(1A):29D-36D.
11. de Jong A., Plat J., Bast A., Godschalk R.W., Basu S., Mensink R.P. Effects of plant sterol and stanol ester consumption on lipid metabolism, antioxidant status and markers of oxidative stress, endothelial function and low-grade inflammation in patients on current statin treatment. Eur J Clin Nutr 2008, 62:263-273.
12. Berendschot T.T., Plat J., de Jong A., Mensink R.P. Long-term plant stanol and sterol ester-enriched functional food consumption, serum lutein/zeaxanthin concentration and macular pigment optical density. Br J Nutr 2009, 101:1607-1610.
13. de Jong A., Plat J., Lutjohann D., Mensink R.P. Effects of long-term plant sterol or stanol ester consumption on lipid and lipoprotein metabolism in subjects on statin treatment. Br J Nutr 2008, 100:937-941.
14. Kelly E., Plat J., Mensink R., Berendschot T. Effects of long term plant sterol and -stanol consumption on the retinal vasculature: a randomized controlled trial in statin users. Atherosclerosis 2011, 214:225-230.
15. Escurriol V., Cofan M., Serra M., Bullo M., Basora J., Salas-Salvado J., et al. Serum sterol responses to increasing plant sterol intake from natural foods in the Mediterranean diet. Eur J Nutr 2009, 48:373-382.
16. Jenkins D.J., Kendall C.W., Nguyen T.H., Marchie A., Faulkner D.A., Ireland C., et al. Effect of plant sterols in combination with other cholesterol-lowering foods. Metabolism 2008, 57:130-139.
17. Fransen H.P., de Jong N., Wolfs M., Verhagen H., Verschuren W.M., Lutjohann D., et al. Customary use of plant sterol and plant stanol enriched margarine is associated with changes in serum plant sterol and stanol concentrations in humans. J Nutr 2007, 137:1301-1306.
18. Eussen S.R., de Jong N., Rompelberg C.J., Garssen J., Verschuren W.M., Klungel O.H. Dose-dependent cholesterol-lowering effects of phytosterol/phytostanol-enriched margarine in statin users and statin non-users under free-living conditions. Public Health Nutr 2011, 14:1823-1832.
19. de Jong N., Zuur A., Wolfs M.C., Wendel-Vos G.C., van Raaij J.M., Schuit A.J. Exposure and effectiveness of phytosterol/-stanol-enriched margarines. Eur J Clin Nutr 2007, 61:1407-1415.
20. Gylling H., Hallikainen M., Raitakari O.T., Laakso M., Vartiainen E., Salo P., et al. Long-term consumption of plant stanol and sterol esters, vascular function and genetic regulation. Br J Nutr 2009, 101:1688-1695.
21. Raitakari O.T., Salo P., Ahotupa M. Carotid artery compliance in users of plant stanol ester margarine. Eur J Clin Nutr 2008, 62:218-224.
22. Celermajer D.S., Sorensen K.E., Bull C., Robinson J., Deanfield J.E. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol 1994, 24:1468-1474.
23. Raitakari O.T., Salo P., Gylling H., Miettinen T.A. Plant stanol ester consumption and arterial elasticity and endothelial function. Br J Nutr 2008, 100:603-608.
24. Hallikainen M., Lyyra-Laitinen T., Laitinen T., Agren J.J., Pihlajamaki J., Rauramaa R., et al. Endothelial function in hypercholesterolemic subjects: effects of plant stanol and sterol esters. Atherosclerosis 2006, 188:425-432.
25. de Jongh S., Vissers M.N., Rol P., Bakker H.D., Kastelein J.J., Stroes E.S. Plant sterols lower LDL cholesterol without improving endothelial function in prepubertal children with familial hypercholesterolaemia. J Inherit Metab Dis 2003, 26:343-351.
26. Jakulj L., Vissers M.N., Rodenburg J., Wiegman A., Trip M.D., Kastelein J.J. Plant stanols do not restore endothelial function in pre-pubertal children with familial hypercholesterolemia despite reduction of low-density lipoprotein cholesterol levels. J Pediatr 2006, 148:495-500.
27. Hallikainen M., Lyyra-Laitinen T., Laitinen T., Moilanen L., Miettinen T.A., Gylling H. Effects of plant stanol esters on serum cholesterol concentrations, relative markers of cholesterol metabolism and endothelial function in type 1 diabetes. Atherosclerosis 2008, 199:432-439.
28. Acuff R.V., Cai D.J., Dong Z.P., Bell D. The lipid lowering effect of plant sterol ester capsules in hypercholesterolemic subjects. Lipids Health Dis 2007, 6:11.
29. Plat J., Brufau G., Dallinga-Thie G.M., Dasselaar M., Mensink R.P. A plant stanol yogurt drink alone or combined with a low-dose statin lowers serum triacylglycerol and non-HDL cholesterol in metabolic syndrome patients. J Nutr 2009, 139:1143-1149.
30. Gagliardi A.C., Maranhao R.C., de Sousa H.P., Schaefer E.J., Santos R.D. Effects of margarines and butter consumption on lipid profiles, inflammation markers and lipid transfer to HDL particles in free-living subjects with the metabolic syndrome. Eur J Clin Nutr 2010, 64:1141-1149.
31. Hansel B., Nicolle C., Lalanne F., Tondu F., Lassel T., Donazzolo Y., et al. Effect of low-fat, fermented milk enriched with plant sterols on serum lipid profile and oxidative stress in moderate hypercholesterolemia. Am J Clin Nutr 2007, 86:790-796.
32. Banuls C., Martinez-Triguero M.L., Lopez-Ruiz A., Morillas C., Lacomba R., Victor V.M., et al. Evaluation of cardiovascular risk and oxidative stress parameters in hypercholesterolemic subjects on a standard healthy diet including low-fat milk enriched with plant sterols. J Nutr Biochem 2010, 21:881-886.
33. Devaraj S., Autret B.C., Jialal I. Reduced-calorie orange juice beverage with plant sterols lowers C-reactive protein concentrations and improves the lipid profile in human volunteers. Am J Clin Nutr 2006, 84:756-761.
34. Clifton P.M., Mano M., Duchateau G.S., van der Knaap H.C., Trautwein E.A. Dose-response effects of different plant sterol sources in fat spreads on serum lipids and C-reactive protein and on the kinetic behavior of serum plant sterols. Eur J Clin Nutr 2008, 62:968-977.
35. Homma Y., Ikeda I., Ishikawa T., Tateno M., Sugano M., Nakamura H. Decrease in plasma low-density lipoprotein cholesterol, apolipoprotein B, cholesteryl ester transfer protein, and oxidized low-density lipoprotein by plant stanol ester-containing spread: a randomized, placebo-controlled trial. Nutrition 2003, 19:369-374.
36. Korpela R., Tuomilehto J., Hogstrom P., Seppo L., Piironen V., Salo-Vaananen P., et al. Safety aspects and cholesterol-lowering efficacy of low fat dairy products containing plant sterols. Eur J Clin Nutr 2006, 60:633-642.
37. Plat J., Brzezinka H., Lutjohann D., Mensink R.P., von Bergmann K. Oxidized plant sterols in human serum and lipid infusions as measured by combined gas-liquid chromatography-mass spectrometry. J Lipid Res 2001, 42:2030-2038.
38. Adcox C., Boyd L., Oehrl L., Allen J., Fenner G. Comparative effects of phytosterol oxides and cholesterol oxides in cultured macrophage-derived cell lines. J Agric Food Chem 2001, 49:2090-2095.
39. de Jong A., Plat J., Mensink R.P. Plant sterol or stanol consumption does not affect erythrocyte osmotic fragility in patients on statin treatment. Eur J Clin Nutr 2006, 60:985-990.
40. Jenkins D.J., Kendall C.W., Nguyen T.H., Teitel J., Marchie A., Chiu M., et al. Effect on hematologic risk factors for coronary heart disease of a cholesterol reducing diet. Eur J Clin Nutr 2007, 61:483-492.
41. Jones P.J., Raeini-Sarjaz M., Jenkins D.J., Kendall C.W., Vidgen E., Trautwein E.A., et al. Effects of a diet high in plant sterols, vegetable proteins, and viscous fibers (dietary portfolio) on circulating sterol levels and red cell fragility in hypercholesterolemic subjects. Lipids 2005, 40:169-174.
42. Miettinen T.A., Gylling H. Plant stanol and sterol esters in prevention of cardiovascular diseases: a review. Int J Clin Pharmacol Ther 2006, 44:247-250.
43. Ikram M.K., de Jong F.J., Vingerling J.R., Witteman J.C., Hofman A., Breteler M.M., et al. Are retinal arteriolar or venular diameters associated with markers for cardiovascular disorders? The Rotterdam Study. Invest Ophthalmol Vis Sci 2004, 45:2129-2134.
44. Tedeschi-Reiner E., Strozzi M., Skoric B., Reiner Z. Relation of atherosclerotic changes in retinal arteries to the extent of coronary artery disease. Am J Cardiol 2005, 96:1107-1109.
45. Wong T.Y., Mosley T.H., Klein R., Klein B.E., Sharrett A.R., Couper D.J., et al. Retinal microvascular changes and MRI signs of cerebral atrophy in healthy, middle-aged people. Neurology 2003, 61:806-811.
46. Wang J.J., Liew G., Klein R., Rochtchina E., Knudtson M.D., Klein B.E., et al. Retinal vessel diameter and cardiovascular mortality: pooled data analysis from two older populations. Eur Heart J 2007, 28:1984-1992.
47. Boden W.E., Probstfield J.L., Anderson T., Chaitman B.R., Desvignes-Nickens P., Koprowicz K., et al. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N Engl J Med 2011, 365:2255-2267.
48. Keech A., Simes R.J., Barter P., Best J., Scott R., Taskinen M.R., et al. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet 2005, 366:1849-1861.
49. Barter P.J., Caulfield M., Eriksson M., Grundy S.M., Kastelein J.J., Komajda M., et al. Effects of torcetrapib in patients at high risk for coronary events. N Engl J Med 2007, 357:2109-2122.
50. Schwartz G.G., Olsson A.G., Abt M., Ballantyne C.M., Barter P.J., Brumm J., et al. Effects of dalcetrapib in patients with a recent acute coronary syndrome. N Engl J Med 2012, 367:2089-2099.
51. Ramsden C.E., Zamora D., Leelarthaepin B., Majchrzak-Hong S.F., Faurot K.R., Suchindran C.M., et al. Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis. BMJ 2013, 346:e8707.